Vermillion Revenue 2006-2019 | VRML

Vermillion revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Vermillion Annual Revenue
(Millions of US $)
2018 $3
2017 $3
2016 $3
2015 $2
2014 $3
2013 $3
2012 $2
2011 $2
2010 $1
2009 $
2008 $0
2007 $0
2006 $18
2005 $27
Vermillion Quarterly Revenue
(Millions of US $)
Q1 2019 $1
Q4 2018 $1
Q3 2018 $1
Q2 2018 $1
Q1 2018 $1
Q4 2017 $1
Q3 2017 $1
Q2 2017 $1
Q1 2017 $1
Q4 2016 $1
Q3 2016 $1
Q2 2016 $1
Q1 2016 $1
Q4 2015 $0
Q3 2015 $0
Q2 2015 $1
Q1 2015 $1
Q4 2014 $2
Q3 2014 $0
Q2 2014 $0
Q1 2014 $0
Q4 2013 $2
Q3 2013 $0
Q2 2013 $0
Q1 2013 $0
Q4 2012 $1
Q3 2012 $0
Q2 2012 $0
Q1 2012 $0
Q4 2011 $1
Q3 2011 $0
Q2 2011 $0
Q1 2011 $0
Q4 2010 $0
Q3 2010 $0
Q2 2010 $0
Q1 2010 $0
Q4 2009
Q3 2009
Q2 2009
Q1 2009
Q4 2008
Q3 2008 $0
Q2 2008
Q1 2008 $0
Q4 2007 $0
Q3 2007
Q2 2007
Q1 2007 $0
Q4 2006 $1
Q3 2006 $5
Q2 2006 $5
Q1 2006 $7
Q4 2005 $6
Q3 2005 $7
Q2 2005 $7
Q1 2005 $7
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.053B $0.003B
Vermillion, Inc. is engaged in the discovery, development and commercialization of novel diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. The Company has diagnostic programs in oncology, hematology, cardiology and women's health. Its tests are intended to guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, to perform additional testing, or to assist in the selection of therapy. Vermillion also intends to address clinical questions related to early disease detection, treatment response, monitoring of disease progression, prognosis and others. Its lead product includes the OVA1 ovarian tumor triage test, which addresses presurgical identification of women who are at high risk of having a malignant ovarian tumor. In addition to the OVA1 Test, Vermillion has development programs in other clinical aspects of ovarian cancer as well as in peripheral arterial disease. Vermillion, Inc. is based in Fremont, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $111.440B 23.74
Intuitive Surgical (ISRG) United States $57.774B 50.53
Edwards Lifesciences (EW) United States $46.125B 44.90
IDEXX Laboratories (IDXX) United States $24.188B 60.68
Fresenius Medical Care AG KGaA (FMS) Germany $20.503B 13.58
Teleflex (TFX) United States $17.004B 36.09
Olympus (OCPNY) Japan $16.202B 121.23
DexCom (DXCM) United States $15.793B 234.04
SONOVA HOLDING (SONVY) Switzerland $15.095B 0.00
Hologic (HOLX) United States $13.462B 21.25
Sysmex ADR (SSMXY) Japan $12.814B 34.54
STERIS (STE) Ireland $12.801B 29.52
Varian Medical Systems (VAR) United States $9.885B 23.65
ABIOMED (ABMD) United States $8.887B 50.87
Masimo (MASI) United States $8.061B 48.91
SARTORIUS AG (SARTF) Germany $6.158B 54.71
Integra LifeSciences Holdings (IART) United States $5.283B 23.58
Globus Medical (GMED) United States $5.058B 32.10
Penumbra (PEN) United States $5.029B 180.68
Elekta AB (EKTAY) Sweden $4.803B 38.32
LivaNova (LIVN) United Kingdom $3.932B 29.99
Tandem Diabetes Care (TNDM) United States $3.700B 0.00
Cantel Medical (CMD) United States $3.673B 37.27
Wright Medical Group (WMGI) Netherlands $2.817B 247.11
Nevro (NVRO) United States $2.626B 0.00
Nihon Kohden (NHNKY) Japan $2.551B 25.67
Integer Holdings (ITGR) United States $2.524B 17.86
Glaukos (GKOS) United States $2.294B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.646B 30.53
Silk Road Medical (SILK) United States $1.299B 0.00
Veracyte (VCYT) United States $1.273B 0.00
OPKO Health (OPK) United States $1.244B 0.00
Natus Medical (NTUS) United States $1.029B 23.97
ORTHOFIX MEDICAL INC (OFIX) United States $1.021B 32.07
CryoLife (CRY) United States $0.997B 94.93
Accelerate Diagnostics (AXDX) United States $0.992B 0.00
Tactile Systems Technology (TCMD) United States $0.957B 118.23
Inogen (INGN) United States $0.949B 23.27
Luminex (LMNX) United States $0.919B 0.00
Corindus Vascular Robotics (CVRS) United States $0.889B 0.00
Pacific Biosciences Of California (PACB) United States $0.886B 0.00
Mesa Laboratories (MLAB) United States $0.852B 39.36
AngioDynamics (ANGO) United States $0.707B 23.12
Quotient (QTNT) Switzerland $0.659B 0.00
AxoGen (AXGN) United States $0.652B 0.00
Intersect ENT (XENT) United States $0.501B 0.00
Si-Bone (SIBN) United States $0.492B 0.00
OrthoPediatrics (KIDS) United States $0.489B 0.00
Fluidigm (FLDM) United States $0.415B 0.00
ViewRay (VRAY) United States $0.411B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.374B 14.38
GenMark Diagnostics (GNMK) United States $0.361B 0.00
Alphatec Holdings (ATEC) United States $0.359B 0.00
Sientra (SIEN) United States $0.350B 0.00
Semler Scientific (SMLR) United States $0.299B 50.55
Accuray (ARAY) United States $0.245B 0.00
RTI Surgical (RTIX) United States $0.240B 36.11
IRadimed (IRMD) United States $0.235B 39.08
CRH Medical (CRHM) Canada $0.234B 81.25
SeaSpine Holdings (SPNE) United States $0.218B 0.00
TransEnterix (TRXC) United States $0.216B 0.00
Stereotaxis (STXS) United States $0.190B 0.00
Neuronetics (STIM) United States $0.182B 0.00
ConforMIS (CFMS) United States $0.141B 0.00
Sensus Healthcare (SRTS) United States $0.107B 0.00
Second Sight Medical Products (EYES) United States $0.096B 0.00
EDAP TMS S.A (EDAP) France $0.094B 0.00
Apollo Endosurgery (APEN) United States $0.073B 0.00
Spectral Diagnostics (EDTXF) Canada $0.065B 0.00
Ekso Bionics Holdings (EKSO) United States $0.062B 0.00
T2 Biosystems (TTOO) United States $0.050B 0.00
Helius Medical Technologies (HSDT) United States $0.050B 0.00
Electromed (ELMD) United States $0.045B 23.09
Xtant Medical Holdings (XTNT) United States $0.036B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.029B 0.00
Restoration Robotics (HAIR) United States $0.028B 0.00
Bioanalytical Systems (BASI) United States $0.028B 0.00
Ra Medical Systems (RMED) United States $0.027B 0.00
Nuvectra (NVTR) United States $0.026B 0.00
ReWalk Robotics (RWLK) Israel $0.023B 0.00
Neovasc (NVCN) Canada $0.022B 0.00
DarioHealth (DRIO) Israel $0.018B 0.00
American Shared Hospital Services (AMS) United States $0.015B 22.00
Lianluo Smart (LLIT) China $0.014B 0.00
Nanovibronix (NAOV) United States $0.012B 0.00
OBALON THERPTCS (OBLN) United States $0.012B 0.00
Avinger (AVGR) United States $0.011B 0.00
Dynatronics (DYNT) United States $0.011B 0.00
ENDRA Life Sciences (NDRA) United States $0.010B 0.00
Cesca Therapeutics (KOOL) United States $0.008B 0.00
Sunshine Heart Inc (CHFS) United States $0.007B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
Allied Healthcare Products (AHPI) United States $0.006B 0.00
Viveve Medical (VIVE) United States $0.006B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.005B 0.00
InspireMD (NSPR) Israel $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00